The 20 Best Non-Muscle Invasive Bladder Cancer Doctors Near Me in Alexandria, VA

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Smith is board certified in American Board Of Urology.

Cynthia Crawford is a Cardiologist practicing medicine in Oxon Hill,, Maryland. Dr. Crawford is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Heart Murmurs, Vitamin D Deficiency, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Michael Kaplan is a Radiologist practicing medicine in Alexandria, Virginia. Dr. Kaplan is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Ascites, Breast Cancer, Pleurisy, Bone Marrow Aspiration, and Liver Embolization.

Dr. Thomas W. Jarrett has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer. Dr. Jarrett earned his medical degree from Emory University School of Medicine, where he also completed his internship. He completed a residency in urology at New York Hospital, followed by a visiting fellowship in urology and ultrasonography in Salzburg, Austria. Dr. Jarrett completed his fellowship in endo-urology at Long Island Jewish Medical Center. He has previously served as the chief of the division of endourology and laparoscopy at the Johns Hopkins Hospital and the chief of the division of urology at Johns Hopkins Bayview Medical Center. Dr. Jarrett has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly. He has also been named a Super Doctor by the Washington Post. Dr. Jarrett is a member of the American Urological Association, the Society of Urologic Oncology and the Endourological Society. Dr. Jarrett has contributed to various publications and presentations on urology, earning him first prize in the World Congress of Endourology essay contest and the Faculty Research Award at Long Island Jewish Medical Center. He has editorial appointments at the Journal of Endourology and the Journal of Laparoendoscopic and Advanced Surgical Techniques. Dr. Jarrett is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Ureterocele, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Jarrett is board certified in American Board Of Urology.

Gregory Bernstein is a Urologist practicing medicine in Alexandria, Virginia. Dr. Bernstein is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Nephrectomy.

James Cooper is a Radiologist and an Interventional Radiologist practicing medicine in Alexandria, Virginia. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Ascites, Lung Cancer, End-Stage Renal Disease (ESRD), Bone Marrow Aspiration, and Gastrostomy.

Jacob Ninan is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Ninan is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Pulmonary Embolism, Saddle Pulmonary Embolism, and Colorectal Cancer.

Ivan Aksentijevich is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Aksentijevich is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma.

Alina Huang is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Huang is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Pulmonary Embolism.

Jeffrey Wong is a Urologist practicing medicine in Alexandria, Virginia. Dr. Wong is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Prostatectomy.

Dr. Jeremy Stone is a specialty care physician board certified in internal medicine and cardiovascular disease. He joined Inova in 2025 and has been practicing since 2012. Prior to joining Inova, Dr. Stone was a noninvasive cardiologist at Nebraska Methodist Health System in Omaha. Dr. Stone is also seeing patients at Inova Cardiology - HealthPlex Franconia-Springfield. Dr. Stone is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Heart Failure, Pulmonary Edema, and Atrial Fibrillation.

Dr. Ramez I. Andrawis is a urologist affiliated with Sibley Memorial Hospital and George Washington University Hospital, where he is an assistant professor of urology and the director of the Urology Lab. He practices out of GW Medical Faculty Associates in Washington, D.C. Dr. Andrawis has an expertise in female urology, benign prostatic hyperplasia, urinary incontinence and reconstructive surgery. Dr. Andrawis earned his undergraduate and medical degree from the University of Cairo in Egypt, where he went on to complete a residency in urology. Dr. Andrawis also completed a residency in urology at the Royal College of Surgeons in Ireland, a general surgery residency at New Britain General Hospital and a urology residency at George Washington University Hospital. Dr. Andrawis has been named a Top Doctor in the Washington, D.C. and Washington-Baltimore areas by Castle Connolly. Dr. Andrawis has contributed to numerous publications on urology. Dr. Andrawis is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Bilateral Hydronephrosis, and Ureteroscopy. Dr. Andrawis is board certified in American Board Of Urology.

Robert Mordkin is a Urologist practicing medicine in Arlington, Virginia. Dr. Mordkin is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Andrew Joel is a Urologist practicing medicine in Arlington, Virginia. Dr. Joel is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

Ross Krasnow is a Urologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 17 years. Dr. Krasnow is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Nephrectomy, and Cystectomy.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy. Dr. Deville is board certified in American Board Of Radiology.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy. Dr. Kressel is board certified in American Board Of Internal Medicine.

Dr. Jones is a radiologist and currently serves as the Chief of Ultrasound at Sibley Memorial Hospital. He received his B.S. from Stanford University and Medical degree from the University of Wisconsin-Madison. He completed a diagnostic residency at the National Naval Medical Center, followed by a Cross-sectional Imaging fellowship at Georgetown University Hospital. Prior to joining Johns Hopkins, Dr. Jones was a staff radiologist at Suburban and Sibley Memorial Hospitals from 2004-2016. He serves as vice chairman of the Sibley Memorial Hospital Department of Radiology. Dr. Jones has subspecialty expertise in abdominal CT, MRI, ultrasound and image-guided biopsies. Dr. Jones is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Collapsed Lung, Fecal Impaction, Pleurisy, and Pleural Effusion. Dr. Jones is board certified in American Board Of Radiology.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer. Dr. Kumar is board certified in American Board Of Radiology.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer. Dr. Halthore is board certified in American Board Of Radiology.